Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification.
Nat Biotechnol. 2018 Dec 17. doi: 10.1038/nbt.4313. Online ahead of print.
Nat Biotechnol. 2018.
PMID: 30556813
Staphylococcal scalded skin syndrome: a rare complication of a common pathogen.
Ahuja M, Hrom J, Woods A, Brown A, Lopez FA.
Ahuja M, et al. Among authors: hrom j.
J La State Med Soc. 2006 Nov-Dec;158(6):274-6; quiz 277.
J La State Med Soc. 2006.
PMID: 17283973
No abstract available.
Item in Clipboard
A rare case of signet ring cell gastric adenocarcinoma.
Dickey A, Hrom J.
Dickey A, et al. Among authors: hrom j.
J Miss State Med Assoc. 2007 Sep;48(9):271-5.
J Miss State Med Assoc. 2007.
PMID: 19292116
Item in Clipboard
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study.
Trněný M, Avigdor A, McKinney MS, Paneesha S, Wahlin BE, Hrom JS, Cunningham D, Morley N, Canales M, Bastos-Oreiro M, Belada D, Devizzi L, Zheng F, DeMarini DJ, Jiang W, Jiang P, Lynch RC.
Trněný M, et al. Among authors: hrom js.
EClinicalMedicine. 2023 Aug 18;63:102130. doi: 10.1016/j.eclinm.2023.102130. eCollection 2023 Sep.
EClinicalMedicine. 2023.
PMID: 37662520
Free PMC article.
Item in Clipboard
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination regimen.
Daniely D, Forouzan E, Spektor TM, Cohen A, Bitran JD, Chen G, Moezi MM, Bessudo A, Hrom J, Eshaghian S, Swift RA, Eades BM, Kim C, Lim S, Berenson JR.
Daniely D, et al. Among authors: hrom j.
Exp Hematol. 2022 Jul;111:79-86. doi: 10.1016/j.exphem.2022.04.003. Epub 2022 Apr 10.
Exp Hematol. 2022.
PMID: 35417741
Free article.
Clinical Trial.
Item in Clipboard
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, Kerr K, Wang C, Ciuleanu TE, Saylors GB, Tanaka F, Ito H, Chen KN, Liberman M, Vokes EE, Taube JM, Dorange C, Cai J, Fiore J, Jarkowski A, Balli D, Sausen M, Pandya D, Calvet CY, Girard N; CheckMate 816 Investigators.
Forde PM, et al.
N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11.
N Engl J Med. 2022.
PMID: 35403841
Free PMC article.
Clinical Trial.
Item in Clipboard
Oxaliplatin as a radiosensitizing agent in rectal cancer.
Huerta S, Hrom J.
Huerta S, et al. Among authors: hrom j.
Anticancer Drugs. 2011 Apr;22(4):317-23. doi: 10.1097/CAD.0b013e328343e076.
Anticancer Drugs. 2011.
PMID: 21285866
Review.
Item in Clipboard
Tissue microarray constructs to predict a response to chemoradiation in rectal cancer.
Huerta S, Hrom J, Gao X, Saha D, Anthony T, Reinhart H, Kapur P.
Huerta S, et al. Among authors: hrom j.
Dig Liver Dis. 2010 Oct;42(10):679-84. doi: 10.1016/j.dld.2010.02.003. Epub 2010 Mar 15.
Dig Liver Dis. 2010.
PMID: 20227932
Item in Clipboard
Cite
Cite